We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Service Q3 Earnings Slated on Nov 3: AMN, AIRM, MEDP
Read MoreHide Full Article
The Q3 earnings season is in full swing right now. As per the latest Earnings Outlook, 332 S&P companies have already disclosed their numbers as of Nov 1. Notably, reported earnings increased 1.9% year over year on a 1.3% rise in revenues, with the beat ratio being 72.9% for earnings and 55.4% for revenues.
The current week is witnessing a plethora of earnings releases as many bigwigs are lined up to report their quarterly numbers. Notably, the third-quarter earnings season is projected to be the first to see positive earnings growth after five consecutive quarters of decline, courtesy of improving growth trends, a string of positive surprises and stability in current-quarter estimates.
Medical is one of the major broader sectors among the 16 Zacks sectors in the S&P 500 cohort expected to report earnings growth in the third quarter. The sector is likely to report earnings growth of 6% on revenue improvement of 7.3%.
Medical service, as defined by Zacks, is a niche area under the medical device subcategory within the broader Medical sector. Accordingly, it holds more promise right now. Currently, the medical services space is ranked the 81st best industry out of the 265 industries covered by Zacks.
Here, we take a sneak peek into three medical services stock stocks set to report their third-quarter figures on Nov 3:
AMN Healthcare Services, Inc. (AMN - Free Report) provides healthcare workforce solutions and staffing services in the United States. It delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, medical coding and consulting, and other services. Last quarter, this company beat the estimate by 17.31%. AMN Healthcare has an Earnings ESP of +1.79% as the Most Accurate estimate stands at 57 cents per share, which is higher than the Zacks Consensus Estimate of 56 cents. Thus, the company is likely to beat on earnings, given the combination of a positive ESP and a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
With respect to the surprise trend, AMN Healthcare surpassed expectations in each of the last four quarters, with an average beat of 21.25%.
Air Methods Corporation is an American publicly owned helicopter operator. Its Domestic Air Medical Division provides emergency medical services to 100,000 patients every year, and serves 48 states and Haiti. Last quarter, this company missed the estimate by 6.67%. Air Methods has an Earnings ESP of -1.96% as the Most Accurate estimate stands at $1.00 per share, lower than the Zacks Consensus Estimate of $1.02 per share. The company carries a Zacks Rank #4 (Sell), which lowers the predictive power of ESP. Please check our Earnings ESP Filter that enables you to find stocks that are expected to come out with earnings surprises.
With respect to the surprise trend, Air Methods surpassed expectations in three of the last four quarters, with the average beat being 9.22%.
Medpace Holdings, Inc. (MEDP - Free Report) is a full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. However, our proven model does not conclusively show that the company is likely to beat on earnings, given the combination of an Earnings ESP of 0.00% – as both the Zacks Consensus Estimate and the Most Accurate estimate are pegged at 34 cents – and a Zacks Rank #3.
Today's investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more. Click here for a peek at this private information >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Service Q3 Earnings Slated on Nov 3: AMN, AIRM, MEDP
The Q3 earnings season is in full swing right now. As per the latest Earnings Outlook, 332 S&P companies have already disclosed their numbers as of Nov 1. Notably, reported earnings increased 1.9% year over year on a 1.3% rise in revenues, with the beat ratio being 72.9% for earnings and 55.4% for revenues.
The current week is witnessing a plethora of earnings releases as many bigwigs are lined up to report their quarterly numbers. Notably, the third-quarter earnings season is projected to be the first to see positive earnings growth after five consecutive quarters of decline, courtesy of improving growth trends, a string of positive surprises and stability in current-quarter estimates.
Medical is one of the major broader sectors among the 16 Zacks sectors in the S&P 500 cohort expected to report earnings growth in the third quarter. The sector is likely to report earnings growth of 6% on revenue improvement of 7.3%.
Medical service, as defined by Zacks, is a niche area under the medical device subcategory within the broader Medical sector. Accordingly, it holds more promise right now. Currently, the medical services space is ranked the 81st best industry out of the 265 industries covered by Zacks.
Here, we take a sneak peek into three medical services stock stocks set to report their third-quarter figures on Nov 3:
AMN Healthcare Services, Inc. (AMN - Free Report) provides healthcare workforce solutions and staffing services in the United States. It delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, medical coding and consulting, and other services. Last quarter, this company beat the estimate by 17.31%. AMN Healthcare has an Earnings ESP of +1.79% as the Most Accurate estimate stands at 57 cents per share, which is higher than the Zacks Consensus Estimate of 56 cents. Thus, the company is likely to beat on earnings, given the combination of a positive ESP and a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here .
With respect to the surprise trend, AMN Healthcare surpassed expectations in each of the last four quarters, with an average beat of 21.25%.
AMN HLTHCR SVCS Price and EPS Surprise
AMN HLTHCR SVCS Price and EPS Surprise | AMN HLTHCR SVCS Quote
Air Methods Corporation is an American publicly owned helicopter operator. Its Domestic Air Medical Division provides emergency medical services to 100,000 patients every year, and serves 48 states and Haiti. Last quarter, this company missed the estimate by 6.67%. Air Methods has an Earnings ESP of -1.96% as the Most Accurate estimate stands at $1.00 per share, lower than the Zacks Consensus Estimate of $1.02 per share. The company carries a Zacks Rank #4 (Sell), which lowers the predictive power of ESP. Please check our Earnings ESP Filter that enables you to find stocks that are expected to come out with earnings surprises.
With respect to the surprise trend, Air Methods surpassed expectations in three of the last four quarters, with the average beat being 9.22%.
AIR METHODS CRP Price and EPS Surprise
AIR METHODS CRP Price and EPS Surprise | AIR METHODS CRP Quote
Medpace Holdings, Inc. (MEDP - Free Report) is a full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. However, our proven model does not conclusively show that the company is likely to beat on earnings, given the combination of an Earnings ESP of 0.00% – as both the Zacks Consensus Estimate and the Most Accurate estimate are pegged at 34 cents – and a Zacks Rank #3.
MEDPACE HLDGS Price and EPS Surprise
MEDPACE HLDGS Price and EPS Surprise | MEDPACE HLDGS Quote
Looking for Ideas with Even Greater Upside?
Today's investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more. Click here for a peek at this private information >>